Join us for a virtual recap of the latest breakthroughs in brain cancer research and treatment presented at the 21st Meeting of the European Association of Neuro-Oncology (EANO) 2026 in Rome, Italy.
Brought to you by the COGNO Education Committee, this webinar brings together speakers and expert panellists who attended the meeting to explore the most impactful findings and their relevance to clinical practice and research in Australia.
We’re also pleased to introduce for the first time in a COGNO post-conference update, a dedicated supportive care update.
Radiation Oncologist (VIC)
Joe is a Specialist Radiation Oncologist at the Peter MacCallum Cancer Centre, Melbourne, Australia. He did his medical training in New Zealand and radiation oncology training in Australia and holds a laboratory-based PhD in tumour immunology from the University of Melbourne. He is passionate about optimising the application of radiation therapy in modern multi-modal oncology paradigms and education of junior radiation oncology trainees.
Prof. Koh is an academic Radiation Oncologist, working as a clinician researcher at Liverpool Hospital, NSW and Conjoint Associate Professor, University of New South Wales. A/Prof. Koh has over 20 years sub-specialty expertise in neuro-oncology and haematological cancers. A/Prof. Koh major research directions include brain tumour research in adult and paediatric patients as well as cancer survivorship research.
Prof. Koh has received research support of over $62 million (CI involvement) in competitive funding, including over $60 million in brain tumour-related projects and $2.2 million in cancer survivorship research. She holds CIB status for the MRFF-funded COGNO trial precision oncology LUMOS2 trial in adult recurrent lower grade glioma, currently recruiting to novel drug interventions across Australia and Canada.
She is co-lead for the largest multi-centre FIG study (FET-PET in Glioblastoma), a MRFF funded trial involving TROG, COGNO and ARTnet.
Her role as the Cooperative Trials Group for Neuro-Oncology (COGNO) Chair, she leads a collaborative network of brain tumour trial sites across Australia, working to develop and deliver both investigator-initiated trials across the collaborative trials landscape as well as working with industry partners. Prof. Koh has played a key role across the COGNO trial portfolio includring MAGMA, VERTU and NUTMEG. She has involvement with ASNO as well as RANZCR Asia-Pacific Radiation Oncology Special Interest Group with outreach activities in the Asia-Pacific.
Professor Georgia Halkett is an experienced cancer supportive care researcher based at Curtin University, where she recently completed a Cancer Council WA Research Fellowship. Her research focuses on understanding and addressing the psychosocial and information needs of people affected by cancer and their carers, improving communication between health professionals and patients, supporting survivorship and return to work, and advancing research in radiation therapy.
Professor Halkett is the Director of Research and Graduate Research for the Curtin School of Nursing and was previously co-lead of the Cancer Domain in the Curtin Medical Research Institute. She also holds an honorary position with the Centre for Nursing Research at Sir Charles Gairdner Hospital. Her leadership roles include serving on the Boards of the Cooperative Trials Group for Neuro-Oncology and the Trans-Tasman Radiation Oncology Group, membership of the Scientific Advisory Committee for the Psycho-oncology Co-operative Research Group, and membership of the European Association of Neuro-Oncology Nurses and Allied Health Committee. She also chairs the Rare Cancers Group for the Clinical Oncological Society of Australia. In 2026 she received the Jenny Chow Award by COGNO which recognises her service to COGNO and the community in the last 10 years.
Professor Halkett practised as a radiation therapist before moving into research. She has led and contributed to a range of studies using randomised controlled trial, mixed methods and qualitative designs, including the Care-IS trial, which evaluated a nurse-led supportive care intervention for carers of people diagnosed with high-grade glioma.
Professor Geraldine O’Neill is Head of the Children’s Cancer Research Unit at The Children’s Hospital at Westmead, Conjoint Professor of Cancer Cell Biology at the University of Sydney, and leader of the Functionally Applied Biology Lab. Following PhD training at the University of Sydney and postdoctoral research at Fox Chase Cancer Center (USA), she established her research program in Australia through NHMRC and NSW Cancer Council fellowships. She leads a translational paediatric cancer research program spanning discovery science to early-phase clinical translation, developing advanced tumour assembloid models to investigate disease mechanisms and accelerate novel immunotherapies, including CAR T-cell therapies.
Dr Vineet Gorolay is a Staff Specialist Neuroradiologist at Royal Prince Alfred Hospital and Chris O'Brien Lifehouse, and Neuroradiology Lead for the Sydney Brain Tumour Bank. He completed his radiology training at Royal Prince Alfred Hospital, followed by an ACGME-accredited Neuroradiology Fellowship at the University of California, San Francisco. He holds a Clinical Lecturer appointment at the University of Sydney and sits on the COGNO Education Committee. His research focuses on neuro-oncology imaging, radiogenomics, and imaging biomarkers in brain tumours, with a current focus on meningioma and glioma.
Education Events
Education Events
Education Events
